Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-10

Clinical Trial Update: Intravesical Bupivacaine on Post-Operative Ureteroscopy Pain [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at the University of Chicago is evaluating intravesical bupivacaine to reduce post-operative pain after ureteroscopy in nephrolithiasis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)

Snippet

Sponsor: University of Chicago | Conditions: Nephrolithiasis | Phase 2 | Status: RECRUITING